Cargando…
Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression
During solid tumor progression, the tumor microenvironment (TME) evolves into a highly immunosuppressive milieu. Key players in the immunosuppressive environment are regulatory myeloid cells, including myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs), which are recrui...
Autores principales: | Wyrobnik, Iris, Steinberg, Miryam, Gelfand, Anat, Rosenblum, Ronen, Eid Mutlak, Yara, Sulimani, Liron, Procaccia, Shiri, Ofran, Yishai, Novak-Kotzer, Hila, Meiri, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262794/ https://www.ncbi.nlm.nih.gov/pubmed/37325437 http://dx.doi.org/10.1080/2162402X.2023.2219164 |
Ejemplares similares
-
Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia
por: Besser, Elazar, et al.
Publicado: (2023) -
Biosynthesis of cannabigerol and cannabigerolic acid: the gateways to further cannabinoid production
por: Kearsey, Lewis J, et al.
Publicado: (2023) -
Anti-Biofilm Activity of Cannabigerol against Streptococcus mutans
por: Aqawi, Muna, et al.
Publicado: (2021) -
Anti-Bacterial Properties of Cannabigerol Toward Streptococcus mutans
por: Aqawi, Muna, et al.
Publicado: (2021) -
The Origin and Biomedical Relevance of Cannabigerol
por: Jastrząb, Anna, et al.
Publicado: (2022)